Transcaval Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Using a Dedicated Self-Expanding Device

Novel dedicated devices allow transcatheter treatment of pure aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System was introduced as the first dedicated and on-label AR transcatheter aortic valve replacement system, implementing a locator-based and calcium-independent anchoring mechan...

Full description

Saved in:

Bibliographic Details
Published in:	JACC. Case reports Vol. 29; no. 10; p. 102320
Main Authors:	Curio, Jonathan, Nienaber, Stephan, Kuhn, Elmar W., Eghbalzadeh, Kaveh, Ahmad, Wael, Mehdiani, Arash, Schröder, Jörg, Körber, Maria Isabel, Wienemann, Hendrik, Baldus, Stephan, Adam, Matti
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Inc 15-05-2024 Elsevier
Subjects:	alternative access aortic regurgitation Case Report electrosurgery TAVR transcaval AR AS aortic regurgitation electrosurgery transcaval STJ alternative access TAVR
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Novel dedicated devices allow transcatheter treatment of pure aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System was introduced as the first dedicated and on-label AR transcatheter aortic valve replacement system, implementing a locator-based and calcium-independent anchoring mechanism. Here, we present the first-in-human transcatheter aortic valve replacement for pure AR via a transcaval access in a patient with prohibitive alternative arterial accesses. [Display omitted]
ISSN:	2666-0849 2666-0849
DOI:	10.1016/j.jaccas.2024.102320